Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (321-330 of 411) with videos related to

Pageof 42
Sort By:
British Journal of Cancer|March 1, 1990
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials CommitteeJ Carmichael, B M Cantwell, K A Mannix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breastR C Leonard, M A Cornbleet, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG)N S Reed, C J Poole, R Coleman, et al.
Cancer Research|May 15, 1995
Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762)P A Vasey, D Bissett, M Strolin-Benedetti, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systemsD J Kerr, T E Wheldon, J G Russell, et al.
Cancer Research|June 1, 1986
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)D J Kerr, S B Kaye, J Graham, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damageD Cunningham, M Soukop, N L Gilchrist, et al.
British Medical Journal (Clinical Research Ed.)|February 23, 1985
Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugsD Cunningham, M Soukop, N L Gilchrist, et al.
Investigational New Drugs|January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanomaS B Kaye, M Clavel, P Dodion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trialT Habeshaw, J Paul, R Jones, et al.
Pageof 42

Showing results (321-330 of 411) with videos related to

Sort By:
Pageof 42
British Journal of Cancer|March 1, 1990
A phase I and pharmacokinetic study of didox administered by 36 hour infusion. The Cancer Research Campaign Phase I/II Clinical Trials CommitteeJ Carmichael, B M Cantwell, K A Mannix, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breastR C Leonard, M A Cornbleet, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2005
A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG)N S Reed, C J Poole, R Coleman, et al.
Cancer Research|May 15, 1995
Phase I clinical and pharmacokinetic study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762)P A Vasey, D Bissett, M Strolin-Benedetti, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
The effect of the non-ionic surfactant Brij 30 on the cytotoxicity of adriamycin in monolayer, spheroid and clonogenic culture systemsD J Kerr, T E Wheldon, J G Russell, et al.
Cancer Research|June 1, 1986
Phase I and pharmacokinetic study of LM985 (flavone acetic acid ester)D J Kerr, S B Kaye, J Graham, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1986
TNO-6 has no effect in gastrointestinal cancer: N-acetyl-glucosaminidase shows renal damageD Cunningham, M Soukop, N L Gilchrist, et al.
British Medical Journal (Clinical Research Ed.)|February 23, 1985
Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugsD Cunningham, M Soukop, N L Gilchrist, et al.
Investigational New Drugs|January 1, 1990
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanomaS B Kaye, M Clavel, P Dodion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trialT Habeshaw, J Paul, R Jones, et al.
Pageof 42